My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 287

    1.

    Tolerance and rebound with zafirlukast in patients with persistent asthma.

    Reid DW, Misso NL, Aggarwal S, Thompson PJ, Johns DP, Walters EH.

    J Negat Results Biomed. 2008 May 19;7:3.PMID: 18489783 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    2.

    Therapeutic effect of zafirlukast as monotherapy in steroid-naive patients with severe persistent asthma.

    Kemp JP, Minkwitz MC, Bonuccelli CM, Warren MS.

    Chest. 1999 Feb;115(2):336-42.PMID: 10027429 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    3.

    Effects of adding a leukotriene antagonist or a long-acting beta(2)-agonist in asthmatic patients with the glycine-16 beta(2)-adrenoceptor genotype.

    Lipworth BJ, Dempsey OJ, Aziz I, Wilson AM.

    Am J Med. 2000 Aug 1;109(2):114-21.PMID: 10967152 [PubMed - indexed for MEDLINE]Related citations

    4.

    The effect of low-dose inhaled fluticasone propionate on exhaled nitric oxide in asthmatic patients and comparison with oral zafirlukast.

    Lanz MJ, Eisenlohr C, Llabre MM, Toledo Y, Lanz MA.

    Ann Allergy Asthma Immunol. 2001 Oct;87(4):283-8.PMID: 11686419 [PubMed - indexed for MEDLINE]Related citations

    5.

    Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma.

    Busse W, Nelson H, Wolfe J, Kalberg C, Yancey SW, Rickard KA.

    J Allergy Clin Immunol. 1999 Jun;103(6):1075-80.PMID: 10359889 [PubMed - indexed for MEDLINE]Related citations

    6.

    Efficacy of zafirlukast in the treatment of patients with bronchial asthma.

    Tsai JJ, Chan SC, Ho CK, Su YC, Feng TC.

    J Microbiol Immunol Infect. 2001 Mar;34(1):63-70.PMID: 11321130 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    7.

    Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction.

    Nathan RA, Bernstein JA, Bielory L, Bonuccelli CM, Calhoun WJ, Galant SP, Hanby LA, Kemp JP, Kylstra JW, Nayak AS, O'Connor JP, Schwartz HJ, Southern DL, Spector SL, Williams PV.

    J Allergy Clin Immunol. 1998 Dec;102(6 Pt 1):935-42.PMID: 9847434 [PubMed - indexed for MEDLINE]Related citations

    8.

    Two first-line therapies in the treatment of mild asthma: use of peak flow variability as a predictor of effectiveness.

    Nathan RA, Minkwitz MC, Bonuccelli CM.

    Ann Allergy Asthma Immunol. 1999 May;82(5):497-503.PMID: 10353583 [PubMed - indexed for MEDLINE]Related citations

    9.

    Exhaled nitric oxide continues to reflect airway hyperresponsiveness and disease activity in inhaled corticosteroid-treated adult asthmatic patients.

    Reid DW, Johns DP, Feltis B, Ward C, Walters EH.

    Respirology. 2003 Dec;8(4):479-86.PMID: 14629652 [PubMed - indexed for MEDLINE]Related citations

    10.

    Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids.

    Virchow JC Jr, Prasse A, Naya I, Summerton L, Harris A.

    Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):578-85.PMID: 10934090 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    11.

    Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.

    Suissa S, Dennis R, Ernst P, Sheehy O, Wood-Dauphinee S.

    Ann Intern Med. 1997 Feb 1;126(3):177-83.PMID: 9027267 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    12.

    Zafirlukast improves pulmonary function in patients with moderate persistent asthma receiving regular inhaled steroids: a prospective randomized control study.

    Huang CJ, Wang CH, Liu WT, Yang MC, Lin HC, Yu CT, Shiao CJ, Tan CC, Yang CK, Kuo HP.

    Chang Gung Med J. 2003 Aug;26(8):554-60.PMID: 14609035 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    13.

    Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.

    Hancox RJ, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Taylor DR.

    Respir Med. 2000 Aug;94(8):767-71.PMID: 10955752 [PubMed - indexed for MEDLINE]Related citations

    14.

    An evaluation of zafirlukast in the treatment of asthma with exploratory subset analyses.

    Tashkin DP, Nathan RA, Howland WC, Minkwitz MC, Simonson SG, Bonuccelli CM.

    J Allergy Clin Immunol. 1999 Feb;103(2 Pt 1):246-54.PMID: 9949315 [PubMed - indexed for MEDLINE]Related citations

    15.

    Effectiveness and tolerability of zafirlukast for the treatment of asthma in children.

    Pearlman DS, Lampl KL, Dowling PJ Jr, Miller CJ, Bonuccelli CM.

    Clin Ther. 2000 Jun;22(6):732-47.PMID: 10929920 [PubMed - indexed for MEDLINE]Related citations

    16.

    Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma.

    Norris V, Choong L, Tran D, Corden Z, Boyce M, Arshad H, Holgate S, O'Connor B, Millet S, Miller B, Rohatagi S, Kirkesseli S.

    J Allergy Clin Immunol. 2005 Oct;116(4):761-7. Epub 2005 Aug 19.PMID: 16210048 [PubMed - indexed for MEDLINE]Related citations

    17.

    Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group.

    Fish JE, Kemp JP, Lockey RF, Glass M, Hanby LA, Bonuccelli CM.

    Clin Ther. 1997 Jul-Aug;19(4):675-90.PMID: 9377612 [PubMed - indexed for MEDLINE]Related citations

    18.

    Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast trials.

    Barnes NC, Miller CJ.

    Thorax. 2000 Jun;55(6):478-83.PMID: 10817796 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    19.

    The effects of add-on zafirlukast treatment to budesonide on bronchial hyperresponsiveness and serum levels of eosinophilic cationic protein and total antioxidant capacity in asthmatic patients.

    Cakmak G, Demir T, Gemicioglu B, Aydemir A, Serdaroglu E, Donma O.

    Tohoku J Exp Med. 2004 Dec;204(4):249-56.PMID: 15572850 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    20.

    Leukotriene E(4)-induced persistent eosinophilia and airway obstruction are reversed by zafirlukast in patients with asthma.

    Laitinen A, Lindqvist A, Halme M, Altraja A, Laitinen LA.

    J Allergy Clin Immunol. 2005 Feb;115(2):259-65.PMID: 15696079 [PubMed - indexed for MEDLINE]Related citations

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...
    You are here: NCBI > Literature > PubMed
    Write to the Help Desk